Nufarm Limited (“Nufarm”) today announced the successful completion of the institutional component (“Institutional Entitlement Offer”) of its fully underwritten 2 for 9 pro rata accelerated renounceable entitlement offer with retail rightstrading (“Entitlement Offer”).
On Tuesday, 24 October 2017, Nufarm announced an Entitlement Offer to raise approximately A$446m. Proceeds from the Entitlement Offer will be used to partially fund the acquisition of a portfolio of crop protection products (“Century Portfolio”) from Adama Agricultural Solutions Ltd (“Adama”) and Syngenta Crop Protection AG and related group companies (“Syngenta”) for US$490 million, also announced on 24 October 2017 (the “Acquisition”).
The Institutional Entitlement Offer closed on Wednesday, 25 October 2017 and raised approximately A$338 million from subscriptions for new fully paid ordinary shares in Nufarm (“New Shares”) at A$7.50 per New Share (“Offer Price”). The Institutional Entitlement Offer attracted strong support from institutional shareholders with a take-up rate by eligible institutional shareholders (excluding Sumitomo who did not participate) of over 95%.
A bookbuild for Institutional Entitlement Offer shortfall shares was conducted on Wednesday, 25 October 2017 to Thursday, 26 October 2017 (“Institutional Shortfall Bookbuild”) and attracted strong demand from both existing shareholders and otherinstitutional investors. The bookbuild cleared at a price of A$8.50 per New Share, which represents a premium of A$1.00 to the Offer Price of A$7.50 per New Share, and a discount of 0.1% to the theoretical ex-rights price (“TERP”) of A$8.51.
Eligible institutional shareholders who elected not to take up their entitlements and certain ineligible institutional shareholders will receive A$1.00 for each entitlement sold through the Institutional Shortfall Bookbuild. This payment will be made on or around Monday, 6 November 2017.
Nufarm’s Managing Director and CEO, Greg Hunt said, “this is an excellent result and a clear endorsement of the value that institutional investors see in the Century Portfolio and Nufarm’s future in the European market.”
“There was strong demand for shortfall shares in the Institutional Shortfall Bookbuild from both existing shareholders and new investors, and we are pleased that institutional shareholders who did not participate will receive a premium of A$1.00 for their renounced entitlements.”
“The next and final stage of the Entitlement Offer is the Retail Entitlement Offer which will open on 1 November 2017 – we encourage Nufarm’s Eligible Retail Shareholders to carefully review the Retail Offer Booklet which will be despatched to them on Tuesday, 31 October 2017 before deciding whether to participate.”
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.